Manitoba Health

Pandemic H1N1 Flu Resources for the Health Sector

The Manitoba guidelines and fact sheets below were developed in consultation with the Infection Control and Occupational Health and Safety group as part of Manitoba’s pandemic response plan. These guidelines, as well as those provided by the Public Health Agency of Canada, are meant to help health care providers as they use their professional judgment in the care of patients.

There may be times when a health care provider is unsure what kind of protection is most appropriate.  In those cases, the health care provider must make a professional judgment based on the specific clinical situation, the type of patient interaction, the environment of care and other personal protection equipment used.

• Guidelines and Fact Sheets
• Forms
• Letters to the Health Sector
• Statistical Information on Pandemic H1N1 Influenza (H1N1 Flu) in Manitoba
• Information from the Public Health Agency of Canada

All documents are in Adobe Acrobat PDF format unless otherwise indicated.

The information on this page is designed to assist Manitoba health care professionals as they respond to the H1N1 flu virus.

Also see:

• For general information, fact sheets and planning tools for non-health care settings: www.gov.mb.ca/flu/index.html
  
  
• For information on Seasonal Flu:
  www.gov.mb.ca/health/flu/index.html
  
  
• For schedules of Regional Health Authority flu clinics:
  http://www.gov.mb.ca/health/flu/clinics.html
  
  
• For a listing of local public health offices:
  www.gov.mb.ca/health/publichealth/offices.html
  

---

Guidelines and Fact Sheets

• Pandemic H1N1 Influenza Vaccine
• Infection Prevention and Control
• Clinical Management

All documents are in Adobe Acrobat PDF format unless otherwise indicated.

Pandemic H1N1 Influenza Vaccine

• Pandemic H1N1 (pH1N1) Influenza Vaccine Dosing Recommendations
  REVISED November 20, 2009
  
  
• Fact Sheet:  Pandemic H1N1 Influenza Vaccine (H1N1 Flu Shot) without Adjuvant: Product Name: Panvax ®
  REVISED November 20, 2009
  
  
• Pandemic H1N1 Influenza, Seasonal Influenza, and Pneumococcal Vaccine Surveillance/Consent Form | [français]
  REVISED November 16, 2009
  
  
• Fact Sheet Pandemic H1N1 Influenza Vaccine (H1N1 Flu Shot) without Adjuvant: GSK Product | [français]
  NEW November 13, 2009
  
  
• Fact Sheet:  Pandemic H1N1 Influenza Vaccine (H1N1 Flu Shot) with Adjuvant:
  Product Name:  Arepanrix™ | [français]
  REVISED November 13, 2009
  
  
• H1N1 Influenza (Flu) Vaccine Fact for Pregnant Women [français]
  NEW November 3, 2009
  
  
• Questions and Answers for Health Care Providers: Pandemic H1N1 (pH1N1) Influenza Vaccine
  UPDATED November 13, 2009
  
  
• Pandemic H1N1 Influenza Vaccine Priority Groups in Manitoba
  October 22, 2009
  • Important Information about pH1N1 Vaccine Priority and Supply
    NEW November 18, 2009
    
    
• User Guide: Report of Adverse Events Following Immunization (AEFI)
  NEW October 27, 2009
  
  
• Report of Adverse Events Following Immunization (AEFI) Form
  UPDATED October 27, 2009
  
  
• AEFI Form Appendix
  NEW October 30, 2009
  
  
• Product Information Leaflet: Pandemic H1N1 Influenza Vaccine with Adjuvant - Health Canada

Infection Prevention and Control

• Community Health And Health Care Office Settings: Summary Of Infection Prevention And Control Guidelines For Influenza Including Pandemic H1n1 Influenza
  NEW October 28, 2009
  
  
• Point Of Care Risk Assessment Tool For Influenza Like Illness Including Novel A/H1n1 Influenza
  NEW October 28, 2009
  
  
• Health Care Workers In The Home Summary Of Infection Prevention Guidelines For Influenza Including Pandemic H1n1 Influenza
  NEW October 28, 2009
  
  
• Infection Prevention and Control Guidelines Influenza-like illness including NOVEL A/H1N1 Influenza:  All Health and Health-Care Settings
  June 19, 2009
  
  
• Acute Care Settings - Summary of Infection Prevention and Control Guidelines
  June 19, 2009
  
  
• Long Term Care Settings - Summary of Infection Prevention and Control Guidelines
  June 19, 2009
  
  
• Teaching Tools
  June 19, 2009
  
  
• Fact Sheet - Effectively Using N95 Respirators 
  
  
• Infection Prevention and Control Guidelines for Non-Healthcare Settings
  

Clinical Management

• Manitoba Interim Guidance for Immunocompromised Individuals Presenting with Symptoms of Acute Respiratory Illness During a Pandemic Influenza Period (H1N1)
  REVISED November 20, 2009
  
  
• Manitoba Interim Clinical Care Guidance for Pregnant and Post-partum Women Presenting with Symptoms of Acute Respiratory Illness During a Pandemic Influenza Period (H1N1)REVISED November 20, 2009

• Clinical Decision-making Algorithm for Adults/Adolescents Presenting with Symptoms of Acute Respiratory Illness During a Pandemic Influenza Period (H1N1)
  REVISED November 20, 2009
  
  
• Manitoba Interim Guidance for Clinicians in Ambulatory Care Settings for Adults and Adolescents Presenting with Symptoms of Acute Respiratory Illness During a Pandemic Influenza Period (H1N1)
  REVISED November 20, 2009
  
  
• Pediatric Clinical Decision-making Algorithm Presenting with Symptoms of Acute Respiratory Illness During a Pandemic Influenza Period (H1N1)
  REVISED November 20, 2009
  

---

Forms

All documents are in Adobe Acrobat PDF format unless otherwise indicated.

• Pandemic H1N1/Severe Respiratory Illness Case Report Form
  REVISED November 12, 2009
  
  
• Pandemic H1N1 Influenza, Seasonal Influenza, and Pneumococcal Vaccine Surveillance/Consent Form | [français]
  REVISED November 16, 2009
  
  
• Hospitalized Influenza Like-Illness (ILI) Reporting Form
  NEW November 3, 2009
  
  
• Report of Adverse Events Following Immunization (AEFI) Form
  UPDATED October 27, 2009
  AEFI Form Appendix
  NEW October 30, 2009

This form is to be used by pharmacists (or designate) each time antivirals from the Manitoba Influenza Pandemic Stockpile are provided to patients.

• Manitoba Pandemic Influenza Antiviral Stockpile Tracking Form
  May 29, 2009

---

Letters to the Health Sector

All documents are in Adobe Acrobat PDF format unless otherwise indicated.

• Health Professionals
• Health Sector Staff
• Dental Community
• Laboratories
• Pharmacy Managers and Pharmacists
• Regional Health Authorities

To all Health Professionals

• Re: Update regarding H1N1 Pandemic Influenza (pH1N1) Testing
  NEW November 19, 2009
  
  
• Re:  H1N1 Pandemic Influenza (pH1N1) Vaccine Information
  NEW November 17, 2009
  
  
• RE:  Treatment of Patients with Suspect Pandemic H1N1 Influenza
  NEW November 3, 2009
  
  
• RE:  H1N1 Pandemic Influenza (pH1N1) Vaccine Information + Appendix
  NEW October 30, 2009
  
  
• Update on Pandemic H1N1 (pH1N1) Influenza
  NEW October 22, 2009
  
  
• Update of the 2009-2010 Seasonal Influenza Vaccine Program
  NEW October 16, 2009
  
  
• Recommendation for the start of the 2009-2010 Seasonal Influenza Vaccine Program
  NEW October 2, 2009
  
  
• Criteria for Part II EDS Coverage for the Pharmacare and Employment and Income Assistance Drug Plans
  August 11, 2009
  
  
• Clinical Decision Making Tool And Manitoba Interim Guidance For Clinicians For Novel Influenza A:H1N1 In Ambulatory Care Settings
  June 26, 2009
  
  
• Occupational Exposure of Health Care Providers to Novel Influenza A:N1N1
  June 25, 2009
  
  
• Criteria for Part III EDS Coverage for the Pharmacare and Employment and Income Assistance Drug Plans
  UPDATED June 25, 2009
  
  
• Novel A: H1N1 Influenza - Management of Cases of Influenza-Like Illness and Severe Respiratory Illness
  June 22, 2009
  
  
• Updates to the Manitoba Guidelines for Novel A/H1N1 influenza
  June 12, 2009
  
  
• Updates to the Clinical Care Guidelines for H1N1 influenza
  May 8, 2009
  


• Update - Interim Guidelines for Novel A/H1N1 Influenza
  May 1, 2009
  
  
• Guidelines for Human Swine Influenza
  April 27, 2009
  
  
• Letter to Health Professionals
  April 23, 2009

To all Health Sector Staff

• Manitoba Health and Healthy Living (MHHL) Guidelines for Use of Personal Respiratory Protection when interacting with Patients with Symptoms of Influenza-like Illness (ILI) or other Respiratory Infections in Acute, Long Term, Pre-Hospital Care Settings
  NEW October 2, 2009
  
  
• Criteria for Part II EDS Coverage for the Pharmacare and Employment and Income Assistance Drug Plans
  August 11, 2009
  
  
• Letter to All Health Care and Regional Health Authority Staff
  April 27, 2009

To the Dental Community

• Infection Prevention and Control Guidelines for Pandemic H1N1 (pH1N1) Influenza
  October 20, 2009

To Laboratories

• Laboratory Considerations in Investigating Novel Influenza A (H1N1) (Swine)
  May 6, 2009

To Pharmacy Managers and Pharmacists

• New Guidelines for Adverse Reaction Reporting of Antiviral Drugs During a Pandemic
  July 24, 2009
  
  
• Letter to Pharmacy Managers and Pharmacists
  June 12, 2009
  • Request of Community Pharmacies to Report Availability of Antivirals
• Pharmacies to Ensure Pandemic Preparedness Plans Are In Place
• Information & Resources on Novel H1N1 Influenza Outbreak for Manitoba Pharmacists
  
  
• Second Request for Community Pharmacies to Acquire Oseltamivir (Tamiflu) for Stock
  June 12, 2009
  
  
• Request from Manitoba Health and Healthy Living Public Health Division to Community Pharmacies to Replenish Inventory Levels of Oseltamivir (Tamiflu)
  May 26, 2009

To Regional Health Authorities

• Immunization Campaigns
  August 14, 2009
  
  
• Planning for the Possibility of Mass Immunization
  May 8, 2009
  

---

Statistical Information on Pandemic H1N1 Influenza (H1N1 Flu) in Manitoba

For the latest statistics on H1N1 flu in Manitoba, please click here.

---

Information from the Public Health Agency of Canada

• Guidelines and Information for HealthCare Providers

To reach staff and for general inquiries:

Public Health Division Manitoba Health and Healthy Living 4th Floor - 300 Carlton St. Winnipeg MB  R3B 3M9  CANADA Phone:  (204) 788-6666